Canaan Partners IX LLC, Director, 10% Owner at CytomX Therapeutics, Inc. (CTMX), sold 51,581 shares at $11.55 ($593K) on 2016-11-16, disclosed to the SEC on 2016-11-16.
Open-market sale of $593k CTMX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.48 | 33,064 | $380K | 64.0% |
| 2 | $11.55 | 18,517 | $214K | 36.0% |
| Total | $11.51 avg | 51,581 | $593K | 100% |
| Filing → |
| CTMX | SELL | 2016-11-21 | $526K | — | Filing → |
| CTMX | SELL | 2016-11-10 | $303K | — | Filing → |
| CTMX | SELL | 2016-06-10 | $487K | — | Filing → |